Industry News
Lung cancer study reveals new drug combination targets
Sep 08, 2014
A Vanderbilt lung cancer patient's exceptional response to different types of therapies spurred research that suggests lung cancer patients with specific gene alterations may benefit from... Read More
Study: Myriad myRisk Hereditary Cancer test identifies 43 percent more patients with breast cancer risk
Sep 08, 2014
Myriad Genetics, Inc. has announced that the Myriad myRisk™ Hereditary Cancer test significantly improved the detection of cancer-causing mutations by 46 percent in patients with breast... Read More
Researchers turn to plants to help treat hemophilia
Sep 08, 2014
People with severe hemophilia typically receive regular injections of these proteins, called clotting factors, as a treatment for the disease. Read More
Study finds that disparities persist in early-stage breast cancer treatment
Sep 08, 2014
Despite its acceptance as standard of care for early stage breast cancer almost 25 years ago, barriers still exist that preclude patients from receiving breast conserving therapy (BCT), with some... Read More
Survival benefit of breast conserving therapy compared to mastectomy in early-stage breast cancer patients
Sep 08, 2014
When factoring in what is now known about breast cancer biology and heterogeneity, breast conserving therapy (BCT) may offer a greater survival benefit over mastectomy to women with early stage... Read More
More convenient once-weekly regimen for breast radiation
Sep 08, 2014
An experimental regimen of once-weekly breast irradiation following lumpectomy provides more convenience to patients at a lower cost, results in better completion rates of prescribed radiation... Read More
Complication of hemophilia treatment prevented in mice
Sep 08, 2014
While healthy people have proteins in their blood called clotting factors that act quickly to plug wounds, hemophiliacs lack these proteins, making even minor bleeds difficult to stop. Read More
Researchers grow prostate cancer organoids in the lab; advances expected in personalized treatment
Sep 08, 2014
Research led by investigators at Memorial Sloan Kettering Cancer Center has shown for the first time that organoids derived from human prostate cancer tumors can be grown in the laboratory, giving... Read More
Gene network identified that is behind untreatable leukemia; discovery suggests possible treatment target
Sep 08, 2014
Researchers have identified a genetic/molecular network that fuels a high-risk and aggressive form of Acute Myeloid Leukemia (AML) and its precursor disease Myelodysplastic Syndrome (MDS) - providing... Read More
Many patients in cancer centers may not experience a dignified death
Sep 08, 2014
A new study that surveyed physicians and nurses in hospitals within cancer centers in Germany suggests that many patients there do not experience a dignified death. Read More
Previous Page Next Page